Trial NCT00063934

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02885
Secondary IDs: 6023 DM02-700 N01CM17003 NCI-2012-02885 P30CA016672

Last trial update was posted on 2019-03-05

MeSH Interventions

Docetaxel Doxorubicin Lenograstim Liposomal doxorubicin Oblimersen

MeSH Conditions

Breast Neoplasms Breast Neoplasms, Male

Other Conditions

Male Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID